Correlation Between Bio Path and Tonix Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bio Path and Tonix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Tonix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Tonix Pharmaceuticals Holding, you can compare the effects of market volatilities on Bio Path and Tonix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Tonix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Tonix Pharmaceuticals.
Diversification Opportunities for Bio Path and Tonix Pharmaceuticals
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Bio and Tonix is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Tonix Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tonix Pharmaceuticals and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Tonix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tonix Pharmaceuticals has no effect on the direction of Bio Path i.e., Bio Path and Tonix Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bio Path and Tonix Pharmaceuticals
Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the Tonix Pharmaceuticals. In addition to that, Bio Path is 1.05 times more volatile than Tonix Pharmaceuticals Holding. It trades about -0.21 of its total potential returns per unit of risk. Tonix Pharmaceuticals Holding is currently generating about 0.06 per unit of volatility. If you would invest 3,700 in Tonix Pharmaceuticals Holding on December 26, 2024 and sell it today you would lose (723.00) from holding Tonix Pharmaceuticals Holding or give up 19.54% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 65.0% |
Values | Daily Returns |
Bio Path Holdings vs. Tonix Pharmaceuticals Holding
Performance |
Timeline |
Bio Path Holdings |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Tonix Pharmaceuticals |
Bio Path and Tonix Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bio Path and Tonix Pharmaceuticals
The main advantage of trading using opposite Bio Path and Tonix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Tonix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tonix Pharmaceuticals will offset losses from the drop in Tonix Pharmaceuticals' long position.Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
Tonix Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Tonix Pharmaceuticals vs. Palisade Bio | Tonix Pharmaceuticals vs. iBio, Common Stock | Tonix Pharmaceuticals vs. Jaguar Animal Health |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Global Correlations Find global opportunities by holding instruments from different markets |